Caricamento...
Safety of vedolizumab in liver transplant recipients: A systematic review
BACKGROUND: The management of inflammatory bowel disease in patients who have previously undergone liver transplantation can be a clinical challenge. There are serious concerns among physicians regarding the use of biologics for treating such immuno-compromised patients. OBJECTIVE: We performed a sy...
Salvato in:
| Pubblicato in: | United European Gastroenterol J |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683639/ https://ncbi.nlm.nih.gov/pubmed/31428411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619858050 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|